These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

838 related items for PubMed ID: 8538617

  • 1. PPAR: a mediator of peroxisome proliferator action.
    Green S.
    Mutat Res; 1995 Dec; 333(1-2):101-9. PubMed ID: 8538617
    [Abstract] [Full Text] [Related]

  • 2. Peroxisome proliferator-activated receptors: finding the orphan a home.
    Green S, Wahli W.
    Mol Cell Endocrinol; 1994 Apr; 100(1-2):149-53. PubMed ID: 8056148
    [Abstract] [Full Text] [Related]

  • 3. The peroxisome proliferator-activated receptor:retinoid X receptor heterodimer is activated by fatty acids and fibrate hypolipidaemic drugs.
    Issemann I, Prince RA, Tugwood JD, Green S.
    J Mol Endocrinol; 1993 Aug; 11(1):37-47. PubMed ID: 8240670
    [Abstract] [Full Text] [Related]

  • 4. [Proliferation of peroxisomes and the hepatocarcinogenic process].
    Palut D.
    Rocz Panstw Zakl Hig; 1997 Aug; 48(1):1-11. PubMed ID: 9273657
    [Abstract] [Full Text] [Related]

  • 5. Peroxisome proliferators and peroxisome proliferator activated receptors (PPARs) as regulators of lipid metabolism.
    Latruffe N, Vamecq J.
    Biochimie; 1997 Aug; 79(2-3):81-94. PubMed ID: 9209701
    [Abstract] [Full Text] [Related]

  • 6. Peroxisome proliferators: a model for receptor mediated carcinogenesis.
    Green S.
    Cancer Surv; 1992 Aug; 14():221-32. PubMed ID: 1330305
    [Abstract] [Full Text] [Related]

  • 7. The peroxisome proliferator activated receptors (PPARS) and their effects on lipid metabolism and adipocyte differentiation.
    Schoonjans K, Staels B, Auwerx J.
    Biochim Biophys Acta; 1996 Jul 26; 1302(2):93-109. PubMed ID: 8695669
    [Abstract] [Full Text] [Related]

  • 8. Conjugated linoleic acid activates peroxisome proliferator-activated receptor alpha and beta subtypes but does not induce hepatic peroxisome proliferation in Sprague-Dawley rats.
    Moya-Camarena SY, Van den Heuvel JP, Belury MA.
    Biochim Biophys Acta; 1999 Jan 04; 1436(3):331-42. PubMed ID: 9989264
    [Abstract] [Full Text] [Related]

  • 9. Role of the peroxisome proliferator-activated receptor (PPAR) in mediating the effects of fibrates and fatty acids on gene expression.
    Schoonjans K, Staels B, Auwerx J.
    J Lipid Res; 1996 May 04; 37(5):907-25. PubMed ID: 8725145
    [Abstract] [Full Text] [Related]

  • 10. Transactivation by PPAR/RXR heterodimers in yeast is potentiated by exogenous fatty acid via a pathway requiring intact peroxisomes.
    Marcus SL, Miyata KS, Rachubinski RA, Capone JP.
    Gene Expr; 1995 May 04; 4(4-5):227-39. PubMed ID: 7787415
    [Abstract] [Full Text] [Related]

  • 11. Peroxisome proliferator-activated receptor alpha required for gene induction by dehydroepiandrosterone-3 beta-sulfate.
    Peters JM, Zhou YC, Ram PA, Lee SS, Gonzalez FJ, Waxman DJ.
    Mol Pharmacol; 1996 Jul 04; 50(1):67-74. PubMed ID: 8700121
    [Abstract] [Full Text] [Related]

  • 12. The molecular mechanism of peroxisome proliferator action: a model for species differences and mechanistic risk assessment.
    Green S, Tugwood JD, Issemann I.
    Toxicol Lett; 1992 Dec 04; 64-65 Spec No():131-9. PubMed ID: 1335174
    [Abstract] [Full Text] [Related]

  • 13. Hydrogen peroxide generation in peroxisome proliferator-induced oncogenesis.
    Yeldandi AV, Rao MS, Reddy JK.
    Mutat Res; 2000 Mar 17; 448(2):159-77. PubMed ID: 10725470
    [Abstract] [Full Text] [Related]

  • 14. Regulation of the peroxisomal beta-oxidation-dependent pathway by peroxisome proliferator-activated receptor alpha and kinases.
    Latruffe N, Cherkaoui Malki M, Nicolas-Frances V, Clemencet MC, Jannin B, Berlot JP.
    Biochem Pharmacol; 2000 Oct 15; 60(8):1027-32. PubMed ID: 11007938
    [Abstract] [Full Text] [Related]

  • 15. Peroxisome proliferator-activated receptors, coactivators, and downstream targets.
    Qi C, Zhu Y, Reddy JK.
    Cell Biochem Biophys; 2000 Oct 15; 32 Spring():187-204. PubMed ID: 11330046
    [Abstract] [Full Text] [Related]

  • 16. Is peroxisome proliferation an obligatory precursor step in the carcinogenicity of di(2-ethylhexyl)phthalate (DEHP)?
    Melnick RL.
    Environ Health Perspect; 2001 May 15; 109(5):437-42. PubMed ID: 11401753
    [Abstract] [Full Text] [Related]

  • 17. Targeting peroxisome proliferator-activated receptors (PPARs) in kidney and urologic disease.
    Guan Y.
    Minerva Urol Nefrol; 2002 Jun 15; 54(2):65-79. PubMed ID: 12185990
    [Abstract] [Full Text] [Related]

  • 18. Identification of a peroxisome proliferator-responsive element upstream of the human peroxisomal fatty acyl coenzyme A oxidase gene.
    Varanasi U, Chu R, Huang Q, Castellon R, Yeldandi AV, Reddy JK.
    J Biol Chem; 1996 Jan 26; 271(4):2147-55. PubMed ID: 8567672
    [Abstract] [Full Text] [Related]

  • 19. Regulation of peroxisome proliferator-activated receptor-alpha mRNA in rat liver.
    Sterchele PF, Sun H, Peterson RE, Vanden Heuvel JP.
    Arch Biochem Biophys; 1996 Feb 15; 326(2):281-9. PubMed ID: 8611035
    [Abstract] [Full Text] [Related]

  • 20. Comparison of dose-response relationships for induction of lipid metabolizing and growth regulatory genes by peroxisome proliferators in rat liver.
    Belury MA, Moya-Camarena SY, Sun H, Snyder E, Davis JW, Cunningham ML, Vanden Heuvel JP.
    Toxicol Appl Pharmacol; 1998 Aug 15; 151(2):254-61. PubMed ID: 9707502
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 42.